Crinetics Pharmaceuticals Inc (CRNX)
Deferred Revenue
$1.67M
Quarterly · Period ending: · USD
CRNX Deferred Revenue
Latest reported$1.67Mperiod ending
Latest reported$1.67Mperiod ending
CRNX Quarterly Deferred Revenue ($0.00 → $1.67M)
Quarterly deferred revenue
High-resolution chart · PNG
CRNX deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 1,669,000 | |
| 1,271,000 | |
| 1,235,000 | |
| 1,642,000 | |
| 1,904,000 | |
| 2,206,000 | |
| 2,176,000 | |
| 1,685,000 | |
| 2,560,000 | |
| 2,463,000 | |
| 2,056,000 | |
| 1,662,000 | |
| 2,080,000 | |
| 2,121,000 | |
| 2,240,000 | |
| 2,320,000 | |
| 2,543,000 | |
| 2,706,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 5,485,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |